Orchestra BioMed (OBIO) Institutional Ownership $3.12 -0.04 (-1.27%) Closing price 04:00 PM EasternExtended Trading$3.17 +0.05 (+1.60%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)CurrentInstitutional OwnershipPercentage53.55%Number ofInstitutional Buyers(last 12 months)20TotalInstitutional Inflows(last 12 months)$16.30MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$594.37K Get OBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OBIO Institutional Buying and Selling by Quarter Orchestra BioMed Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/24/2025 IFP Advisors Inc85,358$229K0.0%-47.3%0.223% 6/27/2025Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127% 5/16/2025Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127% 5/13/2025HighTower Advisors LLC61,000$261K0.0%-10.9%0.159% 5/12/2025Nuveen LLC41,729$179K0.0%N/A0.109% 5/9/2025Deutsche Bank AG20,219$87K0.0%+67.3%0.053% 5/5/2025 IFP Advisors Inc161,921$693K0.0%+106.4%0.423% 2/17/2025Millennium Management LLC21,513$86K0.0%N/A0.057% 2/17/2025Citadel Advisors LLC12,279$49K0.0%-39.0%0.032% 2/17/2025Bank of America Corp DE23,780$95K0.0%+42.0%0.063% Get the Latest News and Ratings for OBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orchestra BioMed and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025Boxer Capital Management LLC238,193$953K0.1%N/A0.627% 2/14/2025Northern Trust Corp236,761$947K0.0%+2.5%0.623% 2/14/2025The Manufacturers Life Insurance Company37,009$148K0.0%+11.1%0.097% 2/14/2025Price T Rowe Associates Inc. MD487,170$1.95M0.0%-5.0%1.282% 2/13/2025Barclays PLC37,786$152K0.0%+18.9%0.099% 2/13/2025Wells Fargo & Company MN13,156$53K0.0%+43.6%0.035% 2/12/2025Geode Capital Management LLC572,441$2.29M0.0%+0.9%1.506% 2/12/2025JPMorgan Chase & Co.49,405$198K0.0%+354.5%0.130% 2/7/2025HighTower Advisors LLC68,500$274K0.0%+34.3%0.180% 1/17/2025SG Americas Securities LLC12,785$51K0.0%+26.0%0.034% 11/21/2024SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032% 11/19/2024Barclays PLC31,785$163K0.0%+281.3%0.084% 11/16/2024Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492% 11/15/2024Barclays PLC31,785$163K0.0%+281.3%0.084% 11/15/2024Jane Street Group LLC19,070$98K0.0%-19.8%0.050% 11/15/2024State Street Corp429,613$2.21M0.0%+12.4%1.130% 11/15/2024RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587% 11/13/2024The Manufacturers Life Insurance Company33,305$171K0.0%-20.9%0.088% 11/12/2024Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574% 11/1/2024 ABLE Financial Group LLC13,402$69K0.0%N/A0.035% 10/3/2024SG Americas Securities LLC10,143$52K0.0%N/A0.028% 8/16/2024SkyView Investment Advisors LLC20,000$163K0.0%N/A0.056% 8/15/2024The Manufacturers Life Insurance Company42,082$343K0.0%+8.4%0.118% 8/1/2024Rhumbline Advisers26,439$215K0.0%+192.7%0.074% 7/26/2024Bank of New York Mellon Corp70,682$576K0.0%+115.7%0.197% 5/15/2024Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596% 5/11/2024 Catalytic Wealth RIA LLC22,261$117K0.0%N/A0.062% 2/1/2024New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010% 10/27/2023 Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014% 10/27/2023 TD Asset Management Inc92,678$808K0.0%+100.0%0.259% Nvidia’s next AI move could catch traders flat-footed (Ad)Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system tracks breaking AI news and shows when to trade.📈 AI-backed. Beginner-friendly. Results proven.Watch the system in action.10/24/2023Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113% 10/18/2023 UMB Bank n.a.3,160$28K0.0%N/A0.009% 10/13/2023Arkadios Wealth Advisors51,595$450K0.0%N/A0.144% 8/24/2023Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744% 8/11/2023Atika Capital Management LLC64,651$453K0.0%N/A0.181% 5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230% 5/15/2023RTW Investments LP5,118,507$100.17M2.1%N/A45.652% 4/18/2023 IFP Advisors Inc2,980$34K0.0%N/A0.027% (Data available from 1/1/2016 forward) OBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OBIO shares? During the previous two years, 33 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($42.18M), Perceptive Advisors LLC ($14.37M), Geode Capital Management LLC ($2.29M), State Street Corp ($2.21M), Price T Rowe Associates Inc. MD ($1.95M), Charles Schwab Investment Management Inc. ($1.12M), and Boxer Capital Management LLC ($953K).Learn more on Orchestra BioMed's institutional investors. What percentage of Orchestra BioMed's stock is owned by institutional investors? 53.55% of Orchestra BioMed's stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings. Which institutional investors have been buying Orchestra BioMed's stock? Of the 27 institutional investors that purchased Orchestra BioMed's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($2.59M), Boxer Capital Management LLC ($238.19K), IFP Advisors Inc ($83.48K), Bank of New York Mellon Corp ($65.25K), Atika Capital Management LLC ($64.65K), Barclays PLC ($52.90K), and Arkadios Wealth Advisors ($51.60K). How much institutional buying is happening at Orchestra BioMed? Institutional investors have bought a total of 3,246,434 shares in the last 24 months. This purchase volume represents approximately $16.30M in transactions. Which of Orchestra BioMed's major shareholders have been selling company stock? The following institutional investors have sold Orchestra BioMed stock in the last 24 months: IFP Advisors Inc ($76.56K), Goldman Sachs Group Inc. ($26.82K), Price T Rowe Associates Inc. MD ($25.49K), The Manufacturers Life Insurance Company ($8.78K), Citadel Advisors LLC ($7.84K), SkyView Investment Advisors LLC ($7.72K), and HighTower Advisors LLC ($7.50K). How much institutional selling is happening at Orchestra BioMed? Institutional investors have sold a total of 165,413 shares in the last 24 months. This volume of shares sold represents approximately $594.37K in transactions. Related Companies BFLY Institutional Ownership DCTH Institutional Ownership TMCI Institutional Ownership SNWV Institutional Ownership CATX Institutional Ownership CLPT Institutional Ownership OM Institutional Ownership RXST Institutional Ownership NPCE Institutional Ownership NNOX Institutional Ownership This page (NASDAQ:OBIO) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Fed Just Froze You Out (Again)The Fed’s holding rates steady—again. No clarity. No yield. No relief. But one income strategy is quietly t...Investors Alley | SponsoredSomething BIG is about to hit the stock marketMost investors won’t see it coming—but Weiss Ratings says a major market event is brewing. Their system jus...Weiss Ratings | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
